MSANTD3
Myb/SANT-like DNA-binding domain-containing protein 3
Also known as: C9orf30, MGC17337, MSD3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96H12
- Gene
- MSANTD3
- Ensembl
- ENSG00000066697
- Chromosome
- 9
- Canonical length
- 275 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
No narrative summary is available for MSANTD3 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
275 residues, UniProt reviewed canonical sequence.
>Q96H12|MSANTD3
1 MQNNEIIKPA KYFSELEKSI LLALVEKYKY VLECKKSDAR TIALKQRTWQ ALAHEYNSQP
61 SVSLRDFKQL KKCWENIKAR TKKIMAHERR EKVKRSVSPL LSTHVLGKEK IASMLPEQLY
121 FLQSPPEEEP EYHPDASAQE SFAVSNRELC DDEKEFIHFP VCEGTSQPEP SCSAVRITAN
181 KNYRSKTSQE GALKKMHEEE HHQQMSILQL QLIQMNEVHV AKIQQIEREC EMAEEEHRIK
241 MEVLNKKKMY WERKLQTFTK EWPVSSFNRP FPNSPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MSANTD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- tongue: 26 nTPM
- skeletal muscle: 20 nTPM
- heart muscle: 16 nTPM
- urinary bladder: 15 nTPM
- midbrain: 15 nTPM
- spinal cord: 14 nTPM
Single-cell type
- brain excitatory neurons: 37 nCPM
- other brain neurons: 35 nCPM
- platelets: 35 nCPM
- oligodendrocyte progenitor cells: 32 nCPM
- brain inhibitory neurons: 32 nCPM
- oligodendrocytes: 32 nCPM
Immune cell
- basophil: 8 nTPM
- MAIT T-cell: 3.8 nTPM
- NK-cell: 3.7 nTPM
- memory CD8 T-cell: 3.2 nTPM
- naive B-cell: 2.8 nTPM
- naive CD4 T-cell: 2.8 nTPM
Brain region
- cerebral cortex: 41 nTPM
- white matter: 38 nTPM
- cerebellum: 33 nTPM
- midbrain: 33 nTPM
- hypothalamus: 30 nTPM
- pons: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 1.35
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MSANTD3 as an antibody target. Whether an autoantibody or antibody against MSANTD3 could matter depends on whether native MSANTD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MSANTD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MSANTD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...